{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:40:38Z","timestamp":1784601638405,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.eplepsyres.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:16:21Z","timestamp":1524489381000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types"],"prefix":"10.1016","volume":"144","author":[{"given":"Yu","family":"Kitazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kakisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-918X","authenticated-orcid":false,"given":"Mayu","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-4171","authenticated-orcid":false,"given":"Nobukazu","family":"Nakasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10072-007-0835-8","article-title":"Juvenile myoclonic epilepsy with generalised and focal electroencephalographic abnormalities: a case report with a molecular genetic study","volume":"28","author":"Bartocci","year":"2007","journal-title":"Neurol. Sci."},{"issue":"22 Pt 2","key":"10.1016\/j.eplepsyres.2018.04.009_bib0010","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/01.wnl.0000313148.34629.1d","article-title":"Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy","volume":"70","author":"Baykan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1059-1311(05)80097-4","article-title":"Characterization of intractable juvenile myoclonic epilepsy: new perspectives on primarily generalized seizures","volume":"2","author":"Dasheiff","year":"1993","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10072-016-2538-5","article-title":"Focal interictal epileptiform discharges in idiopathic generalized epilepsy","volume":"37","author":"Esmail","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.70.2.240","article-title":"Clinical factors of drug resistance in juvenile myoclonic epilepsy","volume":"70","author":"Gelisse","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0045","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.eplepsyres.2014.09.008","article-title":"Seizure outcome in 175 patients with juvenile myoclonic epilepsy-a long-term observational study","volume":"108","author":"H\u00f6fler","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5692\/clinicalneurol.48.727","article-title":"Clinical factors related to treatment resistance in juvenile myoclonic epilepsy","volume":"48","author":"Hirano","year":"2008","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.wnp.0000228496.66246.e0","article-title":"The EEG in selected generalized seizures","volume":"23","author":"Hrachovy","year":"2006","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0060","series-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications","author":"Iber","year":"2007"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.clinph.2015.11.048","article-title":"Focal EEG features and therapeutic response in patients with juvenile absence and myoclonic epilepsy","volume":"127","author":"Japaridze","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0070","first-page":"115","article-title":"Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy","volume":"122","author":"Jayalakshmi","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0013-9580.2004.46803.x","article-title":"Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families","volume":"45","author":"Marini","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0080","first-page":"21","article-title":"A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings","volume":"52","author":"Noachtar","year":"1999","journal-title":"Int. Fed. Clin. Neurophysiol. Electroencephalogr. Clin. Neurophysiol. Suppl."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng1393","article-title":"Mutations in EFHC1 cause juvenile myoclonic epilepsy","volume":"36","author":"Suzuki","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0090","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.seizure.2013.07.008","article-title":"Eye closure sensitivity in juvenile myoclonic epilepsy and its effect on prognosis","volume":"22","author":"Tekin G\u00fcveli","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0095","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/epi.12003","article-title":"Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data","volume":"53","author":"Wandschneider","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0100","series-title":"ATC\/DDD Index 2017","author":"World Health Organization Collaborating Centre for Drug Statistics Methodology","year":"2017"},{"key":"10.1016\/j.eplepsyres.2018.04.009_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.wco.0000162856.75391.b1","article-title":"Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy: review","volume":"18","author":"Zifkin","year":"2005","journal-title":"Curr. Opin. Neurol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:38:31Z","timestamp":1760276311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121118300366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":21,"alternative-id":["S0920121118300366"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.04.009","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}